Background--The transition of aortic valve interstitial cells (AVICs) to myofibroblastic and osteoblast-like phenotypes plays a critical role in calcific aortic valve disease progression. Several microRNAs (miRs) are implicated in stem cell differentiation into osteoblast. We hypothesized that an epigenetic mechanism regulates valvular pro-osteogenic activity. This study examined miR profile in AVICs of calcified valves and identified miRs responsible for AVIC phenotypic transition.
C alcific aortic valve disease (CAVD) affects a large number of elder people (65 or older) and is one of the leading cardiovascular diseases in older adults in industrial countries. 1, 2 This disease is an active pathobiological process involving fibrosis and calcification of aortic valve leaflets. 3 Severe CAVD causes morbidity and results in the second most common cardiovascular surgery performed. 4 The growing prevalence of this disease, associated with prolongation of the human life span, and the unavailability of pharmacological intervention for limitation of disease progression emphasize the importance of investigations of pathobiological mechanisms. In particular, it is critical to elucidate the cellular and molecular mechanisms by which aortic valve leaflets become fibrotic and calcified. Aortic valve interstitial cells (AVICs) play an important role in maintaining valvular structure and function. In normal human aortic valves, AVICs primarily assume a fibroblastic phenotype. 5 They produce extracellular matrix proteins to maintain the valvular structure. In addition, AVICs synthesize and release growth factors and cytokines. 6, 7 In calcified aortic valves, however, the majority of AVICs exhibit a myofibroblastic phenotype. 8 Myofibroblasts express high levels of a-smooth muscle actin (a-SMA), possess elevated proliferative activity, and produce higher levels of extracellular matrix protein. 9, 10 Elevated proliferative activity of myofibroblasts and overproduction of extracellular matrix protein by these cells lead to aortic valve fibrosis and valvular thickening. Currently, the molecular mechanism underlying human AVIC phenotypic transition remains unclear, although several growth factors, such as transforming growth factor-b1 (TGF-b1) and bone morphogenetic protein 2 (BMP-2), have been shown to induce myofibroblastic transition in porcine AVICs. 11, 12 AVICs are also capable of undergoing osteoblast-like phenotypic transition in response to pro-osteogenic stimulation. 13, 14 Interestingly, AVICs of calcified valves display a proosteogenic phenotype with enhanced expression of osteoblast biomarkers, such as runt-related transcription factor 2 (Runx2), osterix (Osx), alkaline phosphatase, and osteopontin. 15 Such AVICs are termed osteoblastic-like cells, and they exhibit pro-osteogenic activities at baseline and assume greater activities when exposed to a variety of stimuli, including TGF-b1 and BMP-2. 16, 17 The osteoblast-like activity of AVICs is believed to be responsible for valve mineralization associated with CAVD. [13] [14] [15] 18 However, the mechanism underlying the transition of AVICs to a pro-osteogenic phenotype is not well understood. In addition, the relationship between AVIC myofibroblastic transition and proosteogenic activities is unclear. Understanding the molecular mechanism underlying AVIC phenotypic transition, particularly the mechanism responsible for the pro-osteogenic phenotype of AVICs in calcified valves, is important for the development of therapeutic strategies for prevention of CAVD progression. MicroRNAs (miRs) are a group of small noncoding 21-to 23-nucleotide-long RNA molecules. 19 Several studies have reported that the expression of miRs can be modulated by Toll-like receptor signaling, such as nuclear factor jB and MAPK pathways, and by pro-osteogenic factors TGF-b and BMP-2. 11, 12, 20 For example, miR-9 expression is upregulated by lipopolysaccharide via the TLR4-MyD88-nuclear factor jB-dependent pathway in human monocytes and neutrophils. 21 Our previous study found that Toll-like receptor 4 or 2 mediates AVIC expression of TGF-b1 or BMP-2 in response to pro-inflammatory stimulation and promotes AVIC pro-osteogenic reprogramming. 22 It is likely that pro-inflammatory mechanisms modulate miR expression through regulation of the production of growth factors. The miRs regulate the expression of protein-coding genes and thus play important roles in the epigenetic regulation of gene expression. Emerging evidence has demonstrated that miRs modulate a wide range of developmental and physiological processes, including cell proliferation and differentiation. 23 Recently, miRs were implicated in the pathophysiology of several cardiovascular diseases and have become intriguing targets for therapeutic intervention. 24 The search for miRs that target Runx2 led to the identification of roles of multiple miRs, including miR204, in the regulation of Runx2 expression in mesenchymal progenitor cells. 25 These miRs downregulate Runx2 to inhibit osteoblast and chondrocyte differentiation. 26 In addition, several studies found that altered expression of miR-30b, miR-26a, and miR-195 is associated with CAVD. 27, 28 Systematic analysis of miR profile in calcified aortic valves and investigation of the role of miRs in AVIC phenotypic transition will provide insights into the molecular mechanism underlying CAVD pathogenesis and may identify therapeutic targets for suppression of CAVD progression.
The purposes of this study were (1) to examine the altered miR expression profile in AVICs of calcified human aortic valves, (2) to identify miRs responsible for the myofibroblastic and osteoblast-like transitions in human AVICs, and (3) to determine the mechanism by which miRs modulate AVIC and valvular pro-osteogenic activity.
Materials and Methods

Materials
Antibody against human Osx was purchased from Santa Cruz Biotechnology, Inc. Antibodies against human a-SMA were purchased from Abcam, Inc. Antibodies against human Runx2, vimentin, phosphatase and tensin homolog (PTEN), phosphorylated protein kinase B (AKT), and total AKT were purchased from Cell Signaling, Inc. The miR mimics and antagomirs, control miR, HiPerFect transfection reagent, other transfection-related reagents, and the EndoFree Plasmid Maxi Kit were purchased from Qiagen. Lentivirus vector expressing miR mimic or antagomir and BLOCK-iT Lentiviral Pol II miR RNAi expression plasmids were purchased from Invitrogen. Lenti a-SMA short hairpin RNA (shRNA), lenti control shRNA, lenti a-SMA open reading frame vector, lenti PTEN open reading frame vector, and lenti control vector were purchased from the Functional Genomics Facility of University of Colorado. Lipofectamine 2000 was purchased from Life Technologies, Inc. Runx2 3 0 untranslated region (UTR) Lenti reporter-Luc vector, the Luciferase Reporter Assay Kit, and TransDux transduction reagent were purchased from System Biosciences. MK-2206 was purchased from Selleck Chemicals. Medium 199 was purchased from Lonza. Osx 3 0 UTR lenti reporter-Luc vector and all other chemicals and reagents were from Sigma-Aldrich.
patients (8 male, aged 50.3AE16.1 years) undergoing heart transplantation due to late stage of cardiomyopathy (Table S1 ). The valve leaflets from transplant-recipient hearts were thin and did not have histological abnormality. This study was approved by the University of Colorado Denver institutional review board. All patients gave informed consent for the use of their valves for this study. AVICs were isolated and cultured using a previously described method. 17, 29, 30 Briefly, valve leaflets were subjected to sequential digestions with collagenase. A high concentration of collagenase (2.5 mg/mL) for 0.5 hour was used to remove endothelial cells. The remaining tissue was then treated with a low concentration of collagenase (0.8 mg/mL) for 3 hours to free the interstitial cells. AVICs were collected by centrifugation. AVIC isolates, which are obtained using this modified protocol are lack of endothelial cells as being verified by von Willebrand factor staining. 29 Cells were maintained in Medium 199 growth medium supplemented with 10% fetal bovine serum, penicillin G (100 U/mL), streptomycin (100 mg/mL), and amphotericin B (0.25 lg/mL). Cells of passages 3 to 6 were used when they reached 80% to 90% confluence.
To determine the role of miRs in regulating AVIC expression of a-SMA, Runx2, and Osx, cells were transfected with miR mimic (5 nmol/L), miR antagomir (50 nmol/L), or control miR (50 nmol/L).
PTEN acts as a negative regulator of AKT, 31 and AKT is known to play a role in myofibroblastic transition. 32, 33 Prediction using mirSVR and TargetScanS confirmed that PTEN is a target of miR-486. PTEN levels and AKT phosphorylation were determined after treatment of cells with miR-486 mimic for 4 to 48 hours. To determine the role of AKT in miR-486-induced a-SMA expression, AKT inhibitor (MK2206, 2.5-5.0 lmol/L) was added to culture medium 60 minutes before the transfection with miR-486 mimic. Lentiviral expression of miRs was applied to determine their effect on calcium deposition. AVICs were incubated in a conditioning medium (growth medium supplemented with 10 mmol/L b-glycerophosphate, 10 nmol/L vitamin D 3 , 10 nmol/L dexamethasone, and 8 mmol/L CaCl 2 ) for 14 days to induce calcium deposition. Alizarin red S staining was applied to evaluate calcium deposition.
MiR Microarray
MiR expression profile was analyzed using Affymetrix GeneChip miRNA 3.0 array according to the manufacturer's instruction (Affymetrix). Biotin-labeled samples were hybridized to miR arrays that were then washed and scanned using Affymetrix GeneChip Scanner 3000. The resulting data were processed with Partek Genomics Suite 6.6 (Partek Inc). Pairwise comparisons of average group values and 1-way ANOVA were performed. Only probes that resulted in a fold change of ≥1.5 and a P value <0.05, with or without Benjamini and Hochberg multiple hypothesis correction, were considered significant. 
Real
Immunoblotting
Immunoblotting was performed, as described previously, 36 to analyze a-SMA, Runx2, and Osx, PTEN, and phosphorylated and total AKT. b-actin levels were examined for normalization of loading. In brief, cell lysates were prepared with a sample buffer (100 mmol/L Tris-HCl, pH 6.8, 2% SDS, 0.02% bromophenol blue, and 10% glycerol). Proteins in cell lysates were fractioned by 4% to 20% SDS-PAGE and subsequently transferred to polyvinylidene difluoride membranes. After being blocked with 5% skim milk solution, membranes were incubated with primary antibodies followed by peroxidaselinked secondary antibodies specific to the primary antibodies. Protein bands were visualized with the enhanced chemiluminescence system. Band density was analyzed using ImageJ software (National Institutes of Health).
Staining for Calcium Deposits
Alizarin red S staining was performed as described previously. 8, 17 Briefly, cell monolayers and tissue section were washed twice with PBS and fixed for 15 minutes in 4% paraformaldehyde, followed by incubation with 0.2% Alizarin red S solution (pH 4.2) at room temperature. Cells and tissue section were washed with distilled water. Alizarin red S stains were examined and photographed with a Nikon Eclipse TS100 microscope. To quantitatively analyze Alizarin red S staining, Alizarin red S stains were bleached with 10% acetic acid at 85°C. Supernatant was spectrophotometrically analyzed at 450 nm. 37 
Immunofluorescence Staining
Immunofluorescence staining was performed, as described previously, 8 to detect a-SMA in human AVICs. After permeabilization with an ethanol/acetone mixture, cells on chamber slides were fixed in 4% paraformaldehyde and incubated with a rabbit polyclonal antibody against human a-SMA overnight at 4°C. After washing with PBS, cells were incubated with Cy3-tagged secondary antibody against the primary antibody (imaged on the red channel). Nuclei were stained with bisbenzimide (4 0 ,6-diamidino-2-phenylindole, imaged on the blue channel) and glycoproteins on cell surfaces with Alexa 488-tagged wheat germ agglutinin (imaged on the green channel).
Microscopy was performed with a Leica DM 5500 digital microscope (Leica Microscopy und System GmbH).
Human Aortic Valve Culture
Ex vivo culture of human aortic valve leaflet was performed following the method described by Peacock and colleagues. 38 In brief, aortic valve leaflets from explanted hearts of 8 heart transplant recipients were used. The valvular tissue used was comparable in size. Each piece of tissue was placed on a filter membrane (0.2-lm pore size) and immersed in Medium 199 growth medium. After overnight incubation, conditioning medium (growth medium with 10 mmol/L b-glycerophosphate, 10 nmol/L vitamin D3, 10 nmol/L dexamethasone, and 8 mmol/L CaCl 2 ) was applied. Lentivirus expressing miR-486 mimic, miR-204 antagomir, or irrelevant oligonucleotide was added to determine the effect of expression of miR-486 and inhibition of miR-204 function on aortic valve tissue osteogenic activity.
Statistical Analysis
The Kolmogorov-Smirnov test was used to test for normality of distribution. Results are expressed as meanAESE or as median and 95% CI when the Kolmogorov-Smirnov test indicated a nonnormal distribution. Comparisons between groups were performed using StatView software (Abacus Concepts) with 1-way ANOVA with the post hoc Bonferroni/ Dunn test and independent-samples t test, and differences were confirmed with the Mann-Whitney U and Kruskal-Wallis H tests. A difference was considered significant at P≤0.05.
Results The Pro-Osteogenic Phenotype of AVICs of Calcified Valves Is Associated With Upregulated miR-486 Expression and Downregulated miR-204 Expression
AVICs from noncalcified tissue of calcified aortic valves had significantly higher levels of myofibroblastic biomarker a-SMA (Figure 1 ), whereas the levels of fibroblastic biomarker vimentin were moderately but insignificantly elevated in these cells ( Figure S1 ). AVICs of calcified valves also had elevated levels of osteogenic transcription factors Runx2 and Osx ( Figure 1 ). Furthermore, such cells formed more calcium deposits when cultured in the conditioning medium ( Figure 1 ). To understand whether the elevated pro-osteogenic activity in AVICs of calcified valves is associated with altered miR expression, we applied microarray analysis to compare miR profiles in AVICs isolated from normal and calcified valves. Interestingly, microarray analysis identified only 26 miRs that (Tables 1 and 2) . Real-time quantitative reverse transcription-polymerase chain reaction data in Figure 1C confirmed that AVICs from noncalcified tissue of calcified valves have markedly higher levels of miR-486 (2.1-fold of those in AVICs of normal valves; P<0.05; independentsamples t test and nonparametric Mann-Whitney U test) and significantly lower levels of miR-204 (40% of those in AVICs of normal valves; P<0.05; independent-samples t test and nonparametric Mann-Whitney U test).
Coexpression of miR-486 Antagomir and miR-204 Mimic Suppresses the Pro-Osteogenic Activity of AVICs of Calcified Valves
We infected AVICs from calcified valves with lentivirus that expresses miR-486 antagomir, miR-204 mimic, or both and examined calcium deposit formation. The results in Figure 2 show that lentiviral expression of miR-486 antagomir alone or miR-204 mimic alone reduced calcium deposit formation in AVICs of calcified valves by 31.6% and 28.9%, respectively (P<0.05; ANOVA and nonparametric Kruskal-Wallis H test), whereas expression of irrelevant miR had no effect. Moreover, a combination of miR-486 antagomir and miR-204 mimic reduced the levels of calcium deposit formation close to baseline levels in AVICs of normal valves. Thus, both increased levels of miR-486 and decreased levels of miR-204 are involved in the mechanism underlying the elevated pro-osteogenic activity in AVICs of calcified valves.
MiR-486 Upregulates a-SMA Expression in AVICs Through the AKT Signaling Pathway
The results in Figure 3A show that a-SMA levels in AVICs of calcified valves were reduced by transfection of miR-486 antagomir but were not affected by transfection of miR-204 mimic. In addition, miR-486 mimic upregulated a-SMA Figure 3B ). The data of immunofluorescence analysis confirmed the effect of miR-486 mimic on a-SMA levels in AVICs of normal valves ( Figure 3B ). It appears that miR-486 upregulates a-SMA expression in human AVICs, and the increased levels of miR-486 contribute to the mechanism underlying enhanced a-SMA expression in AVICs of calcified valves.
We observed that the expression of miR-486 mimic caused a reduction in cellular PTEN levels that is accompanied by AKT phosphorylation ( Figure 3C ). The effect of miR-486 mimic on a-SMA levels was essentially lost when the AKT signaling pathway was inhibited with a specific inhibitor ( Figure 3C ). Conversely, miR-204 antagomir caused a marked increase in the levels of Runx2 and Osx in AVICs of normal valves ( Figure 4B ). Therefore, miR-204 negatively regulates the expression of both Runx2 and Osx in human AVICs, and overexpression of these 2 osteogenic transcription factors in AVICs of calcified valves is due to a deficiency of miR-204. antagomir reduces a-SMA levels at day 3 after transfection, whereas transfection with miR-204 mimic or control microRNA (miR-C) has no effect. Data are expressed as meanAESE or median and 95% CI (a-SMA levels in diseased cells treated with miR-204 mimic or control miR). n=6 separate experiments using distinct cell isolates; ANOVA and nonparametric Kruskal-Wallis H test; *P<0.05 vs untreated AVICs of calcified valves; †
P<0.05 vs AVICs of calcified valves plus miR-C. B, AVICs of normal valves were transfected with miR-486 mimic or control microRNA (miR-C).
Representative immunoblots of 5 separated experiments and quantitative analysis show that miR-486 mimic increases a-SMA levels in normal AVICs, whereas miR-204 antagomir has no effect. Representative immunofluorescence images show the effect of miR-486 mimic on a-SMA expression. Scale bar=100 lm. C, Representative immunoblots show that miR-486 mimic reduces cellular PTEN levels at 4 to 48 hours and induces AKT phosphorylation in normal AVICs. Inhibition of AKT with MK2206 abrogates the effects of miR-486 mimic on a-SMA expression. Data are expressed as meanAESE or median and 95% CI (a-SMA levels). n=7 in separate experiments using distinct cell isolates; ANOVA and nonparametric Kruskal-Wallis H test; *P<0.05 vs control normal AVICs or normal AVICs plus miR-C; # P<0.05 vs normal AVICs plus miR-486 mimic.
MiR-486 Mimic and miR-204 Antagomir Have a Synergistic Effect on the Upregulation of Valvular Pro-Osteogenic Activity
We observed that miR-486 mimic also upregulated the expression of Runx2 and Osx in AVICs of normal valves, although the effect of miR-486 mimic was moderate in comparison to that of miR-204 antagomir ( Figure 5A ). Interestingly, cells produced greater levels of Runx2 and Osx when they were cotransfected with miR-486 mimic and miR-204 antagomir ( Figure 5A ). Furthermore, AVICs of normal valves formed significantly more calcium deposits when they were subjected to a conditioning medium following lentiviral coexpression of miR-486 mimic and miR-204 antagomir ( Figure 5B ). More importantly, lentiviral coexpression of miR-486 mimic and miR-204 antagomir resulted in greater calcium deposition in human aortic valve tissue ( Figure 5C ). Thus, miR-486 elevation and miR-204 deficiency synergize in promotion of Runx2 and Osx expression as well as proosteogenic activity in human aortic valves.
Neither Runx2 nor Osx could be a direct target of miR-486. Because miR-486 upregulates a-SMA expression (a biomarker of myofibroblastic transition), it is likely that miR-486 overexpression induces myofibroblastic transition in AVICs to enhance pro-osteogenic activity. To verify a link between myofibroblastic transition and enhanced proosteogenic activity, we applied lentiviral expression of a-SMA shRNA to block the myofibroblastic transition induced by miR-486 mimic in normal AVICs. The immunoblotting results in Figure 6A show that lentiviral a-SMA shRNA reduced a-SMA levels in AVICs of normal valves at day 3 after infection in the absence of stimulation. The immunofluorescence images show that lentiviral a-SMA shRNA abolished the effect of miR-486 mimic on a-SMA expression ( Figure 6A ). Inhibition of a-SMA expression essentially abrogated the effect of miR-486 mimic on Runx2 and Osx levels ( Figure 6B ). Conversely, overexpression of a-SMA in normal AVICs enhanced the expression of Runx2 and Osx ( Figure 6C ). Consequently, upregulation of a-SMA expression appears to be the mechanism underlying the effect of miR-486 on pro-osteogenic activity in human AVICs.
Discussion
CAVD is a leading cardiovascular disease in older adults. Progressive calcification of aortic valve leaflets eventually results in valvular dysfunction. Although aortic valve replacement surgery is an available therapy, the replaced valve can fail, and valve replacement surgery is associated with several complications. 39 Pharmacological intervention for limitation of this disease progression is desperately needed and relies on identification of therapeutic targets. AVICs of calcified valves undergo profibrogenic and pro-osteogenic transitions and thus play an important role in CAVD progression 17,40 ; however, the mechanism underlying AVIC phenotypic transition remains poorly understood. Using a systematic approach, we found that the expression of miR-486 and miR-204 is markedly altered in AVIC isolates from noncalcified tissue of calcified human aortic valves, and altered expression of these 2 miRs is responsible for the AVIC pro-osteogenic phenotype. Additional novel findings of the present study include that miR-486 upregulates a-SMA expression through the PTEN-AKT pathway, and miR-204 negatively regulates the expression of both Runx2 and Osx through posttranscriptional modulation. Moreover, miR-486 elevates AVIC pro-osteogenic activity (expression of Runx2 and Osx and formation of calcium deposits) by inducing myofibroblastic transition (overexpression of a-SMA). These findings provide insights into the mechanism underlying CAVD pathogenesis and may help identify therapeutic targets for suppression of CAVD progression. AVICs form normal aortic valves do not have spontaneous pro-osteogenic activity, whereas cells from calcified aortic valves display elevated pro-osteogenic activity. In the present study, we confirmed that AVICs isolated from noncalcified areas of calcified aortic valves have higher levels of a-SMA, Runx2 and Osx, and form greater amounts of calcium deposits in vitro in the presence of a conditioning medium that contains higher levels of calcium and phosphate. Increased levels of miR-486 and decreased levels of miR-204 are prominent in the list of altered miRs in AVICs of calcified valves. miR-204 has been found to suppress osteoblastic differentiation in C2C12 mesenchymal progenitor cells and stem cells by negative regulation of Runx2. 25, 42 In addition, miR-486 can upregulate AKT activity through negative regulation of PTEN expression. 43 AKT signaling is important in endothelial-to-mesenchymal transition and myofibroblastic transformation in fibroblasts from the heart and lungs. Consequently, it is likely that both increased expression of miR-486 and decreased expression of miR-204 in AVICs of calcified valves contribute to the mechanism underlying the pro-osteogenic phenotype in human AVICs. The results of experiments using the lentiviral expression approach support this notion because the expression of miR-486 antagomir alone or miR-204 mimic alone results in a reduction of calcium deposition in AVICs of calcified valves. Moreover, coexpression of miR-486 antagomir and miR-204 mimic essentially abolishes calcium deposition in AVICs of calcified valves. The results of experiments using the miR-486 loss-offunction and miR-204 gain-of-function approaches demonstrate that both miR-486 and miR-204 are involved in upregulating the pro-osteogenic activity of AVICs of calcified valves and that miR-486 is a positive regulator and miR-204 is a negative regulator of AVIC pro-osteogenic activity. Increased levels of miR-486 and decreased levels of miR-204 may exert an effect on aortic valve pro-osteogenic activity.
Our microarray data also show altered expression of miR-602 (%2.1-fold increase) and miR-411 (%1.9-fold decrease) in AVICs of calcified valves. These 2 miRs have been found to modulate the expression of mediators involved in the degradation of extracellular matrix proteins in cartilage and to play a role in protection against osteoarthritis through downregulation of inflammatory responses. 44, 45 Because proinflammatory mechanisms also play a role in CAVD progression, miR-602 and miR-411 may contribute to the aortic valve pathobiology associated with CAVD. Their potential roles in aortic valve inflammation and calcification need to be determined in future studies. It remains unknown from the present study what is responsible for the altered expression of miR-486 and miR-204 in AVICs of calcified valves. The levels of TGF-b1 and BMP-2 are significantly increased in calcified aortic valves, and these 2 growth factors are potent in elevation of AVIC pro-osteogenic activity. 22 It is possible that TGF-b1 and BMP-2 are involved in the mechanism underlying the altered expression of miRs in AVICs of calcified valves. In addition, multiple pro-inflammatory mediators have been identified in calcified human aortic valves. 46 Our previous studies demonstrate that exogenous and endogenous ligands of Toll-like receptors are capable of elevating the pro-osteogenic activity in human AVICs. 8, 17, 29, [47] [48] [49] It is noteworthy that activation of certain Toll-like receptors in human AVICs by pro-inflammatory stimuli leads to overproduction of TGF-b1 and/or BMP-2. 
MiR-486 Induces Myofibroblastic Transition in Human AVICs to Promote Pro-Osteogenic Activity
Fibroblast is the most abundant cell type within normal heart valves, whereas myofibroblasts constitute a small fraction. Our previous studies show that myofibroblasts are abundant in calcified aortic valves. 8 In the present study, we found miR-486 is increased in AVICs of calcified valves. In determining the role of miR-486 in AVIC myofibroblastic transition, we found that miR-486 mimic upregulates the expression of a-SMA, a biomarker of myofibroblasts, although it does not induce myofibroblastic transition uniformly in AVIC culture, likely due to cell heterogeneity. Conversely, inhibition of AKT signaling is important in endothelial-to-mesenchymal transition and myofibroblastic transformation in fibroblasts from the heart and lungs. 32 activity through negative regulation of PTEN expression. 43 The phosphoinositide phosphatase PTEN converts PIP3 to PIP2 and thereby negatively modulates AKT activity, 31 thus downregulation of PTEN can upregulate AKT phosphorylation. 43, 53 We evaluated the role of the AKT pathway in mediating a-SMA expression induced by miR-486 mimic. miR-486 decreases PTEN expression and induces AKT phosphorylation in human AVICs. Importantly, inhibition of AKT with a specific inhibitor abolishes a-SMA expression induced by miR-486 mimic. The results suggest that the PTEN-AKT pathway is involved in the upregulation of a-SMA expression and myofibroblastic transition mediated by miR-486 in human AVICs. These findings are consistent with previous reports that the AKT signaling pathway modulates a-SMA expression in lung fibroblasts and porcine AVICs. 33, 54 It should be noted that overexpression of miR-204 downregulates AKT signaling in cancer cells and leads to inhibition of cellular migration and invasion. 55 Nevertheless, in our preliminary experiments, we found no change in AKT phosphorylation in human AVICs treated with miR-204 mimic or antagomir; therefore, miR-204 is unlikely to be involved in the modulation of AKT signaling in human AVICs. Interestingly, we observed that normal AVICs that coexpress miR-486 mimic and miR-204 antagomir produce markedly higher levels of Runx2 and Osx and exhibit greater calcium deposition than cells that express miR-486 mimic alone or miR-204 antagomir alone. Our ex vivo data demonstrate that coexpression of miR-486 mimic and miR-204 antagomir also results in greater calcium deposition in normal human aortic valve tissue. It seems that increased levels of miR-486 and decreased levels of miR-204 have a synergistic effect in upregulating valvular pro-osteogenic activity.
When evaluating the effect of miR-486 alone on the proosteogenic activity, we noted that miR-486 mimic can cause moderate increases in Runx2 and Osx levels as well as calcium deposition. A question is how miR-486 upregulates AVIC pro-osteogenic activity and synergizes with miR-204 deficiency in upregulation of the pro-osteogenic activity in AVICs and valvular tissue. In further experiments, we determined the potential role of myofibroblastic transition, reflected by overexpression of a-SMA. Interestingly, the effect of miR-486 mimic on pro-osteogenic activity is abolished by inhibition of the expression of a-SMA with shRNA. Furthermore, overexpression of a-SMA promotes the expression of Runx2 and Osx in normal AVICs in the absence of miR-486 mimic expression. Our results suggest that miR-486 upregulates pro-osteogenic activity in human AVICs through inducing myofibroblastic transition. In this regard, several studies indicate that myofibroblasts in the aortic valve may have elevated pro-osteogenic potential. 18, 56 Our findings provide evidence that human AVICs that overexpress a-SMA have elevated pro-osteogenic activity. It appears that a synergistic effect of miR-486 overexpression and miR-204 deficiency could exaggerate pro-osteogenic activity in AVICs and valvular tissue; however, it is unclear from this study whether myofibroblasts and "osteoblast-like cells" in the aortic valve are the same and how a-SMA overexpression leads to the upregulation of Runx2 and Osx. Nevertheless, our loss-of-function and gain-of-function experiments provide evidence that miR-486 and miR-204 synergistically upregulate Runx2 and Osx expression. Further study will address the impact of a-SMA overexpression or myofibroblastic transition on the levels of these 2 miRs and on the activities of Runx2 and Osx genes.
Conclusion
Increased levels of miR-486 and decreased levels of miR-204 are characteristics of AVICs from calcified human aortic valves and are responsible for the enhanced pro-osteogenic activity observed in such cells. Normal AVICs that overexpress miR-486 exhibit a myofibroblastic phenotype, whereas normal AVICs that overexpress miR-204 antagomir become proosteogenic. miR-486 promotes the pro-osteogenic activity through induction of myofibroblastic transition. A combination of increased miR-486 and decreased miR-204 synergistically upregulates the pro-osteogenic activity in human AVICs and aortic valve tissue (Figure 7) . These novel findings suggest that altered expression of miR-486 and miR-204 plays a significant role in promoting valvular pro-osteogenic activity and that modulation of the expression of these 2 miRs may have therapeutic potential for suppression of CAVD progression.
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